A novel delivery method leverages the glymphatic system to transport genetic material to glial cells, bypassing the blood-brain barrier. This approach aims to reduce systemic toxicity while providing a method for treating neurodegenerative conditions.

Researchers have identified a link between cognitive impairment in ME/CFS patients and compromised glymphatic system function. This discovery provides a mechanistic explanation for brain fog and highlights potential areas for future diagnostic and clinical development.